Katkin Keith 4
4 · Emergent BioSolutions Inc. · Filed May 28, 2025
Insider Transaction Report
Form 4
Katkin Keith
Director
Transactions
- Sale
Common Stock
2025-05-23$6.30/sh−7,844$49,417→ 86,431 total
Footnotes (2)
- [F1]Represents the number of shares sold by the Reporting Person. Shares were sold pursuant to a Rule 10b5-1 trading plan, dated November 8, 2024, for the purpose of satisfying tax obligations relating to the vesting of RSUs on May 22, 2025.
- [F2]For reporting purposes, sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $6.22 - $6.35. The Company maintains a record of the transactions and copies will be provided upon request.